Scafetta R, Troiano R, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Donato M, Foderaro S, Venuti F, Vilardi FA, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Cesa A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Garrone O, Domati F, Piombino C, Lisa FSD, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, Lisi D, Orsaria P, Grasso A, Ippolito E, Ramella S, Visani L, Livi L, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Bonomo MV, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri MA, Giorgi U, Vici P, Toss A, Ruatta F, Laurentiis M, Villa F, Berardi R, Minelli M, Altomare V, Vernieri C, Curigliano G, Chirco A, D'Alessandro S, Vincenzi B, Tonini G, Santini D, Pantano F

Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

Eur J Cancer 2026; 116703. doi: 10.1016/j.ejca.2026.116703

Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Venuti F, Vilardi FA, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, La Cesa A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Chirco A, D'Alessandro S, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Grasso A, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Bonomo MV, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri MA, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Altomare V, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

Oncologist 2026; . doi: 10.1093/oncolo/oyag146

Pseftogas A, Bordini J, Gavriilidis G, Frenquelli M, Campanella A, Rovida A, Morello G, Gerousi M, Theodosiou E, Fragkouli SC, Vasileiou V, Sklaviadis T, Dafou D, Mosialos G, Tripodo C, Psomopoulos F, Winkler TH, Stamatopoulos K, Ghia P, Xanthopoulos K

The deubiquitinase activity of CYLD is required for B cell differentiation.

Cell Death Dis 2026; . doi: 10.1038/s41419-026-08555-x

Becherini C, Blondeaux E, Delucchi V, Visani L, Kim HJ, Coussy F, Bernstein-Molho R, Di Meglio A, Hilbers FS, Pogoda K, Kwong A, Agostinetto E, Baten A, Bajpai J, Balmana J, Moore HCF, Partridge AH, Rousset-Jablonski C, Phillips KA, Toss A, Renaud T, Ferrari A, Peccatori FA, Sanchez L, Paluch-Shimon S, Cui W, Wong SM, Ryu JM, Fruscio R, Lee MK, Vernieri C, Matikas A, Couch FJ, De Marchis L, Dieci MV, Aguilar-Y-Mendez D, Hwang SE, Rozenblit M, Can Güven D, Mrinakova B, Harbeck N, Sanchez-Bayona R, Boni L, Lambertini M, Meattini I

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Radiother Oncol 2026; 111523. doi: 10.1016/j.radonc.2026.111523

Siciliano MC, Bertolazzi G, Glaser S, Granai M, Lori C, Boccacci R, Yellapragada SV, Vannucchi M, Ferrara D, Dreval K, Marafioti T, Quintanilla-Martinez L, Falko F, Morin RD, Bellan C, Ott G, Tripodo C, Siebert R, Lazzi S, Mbulaiteye SM, Leoncini L

Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activation.

Blood Adv 2026; . doi: 10.1182/bloodadvances.2025018518

Bolli E, Wirapati P, Hicham M, Xie Y, Siwicki M, Duval F, Goubet AG, Kiss M, Zitti B, Zwahlen T, Mcdowell S, Bill R, Angerani S, Engblom C, Anderson S, Jiang A, Hartley O, Sykes DB, Jankovic M, Fournier N, Gunzer M, Tarussio D, Tissot S, Sadow PM, Faquin WC, Sade-Feldman M, Weissleder R, Pai S, Mercier F, Manguso R, Pittet MJ

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.

Cancer Cell 2026; 624-640.e12. doi: 10.1016/j.ccell.2026.01.006

Avolio M, Leto SM, Sassi F, Lupo B, Grassi E, Catalano I, Zanella ER, Vurchio V, Cottino F, Tsantoulis PK, Lazzari L, Luraghi P, Ferri M, Galimi F, Berrino E, Bellomo SE, Viviani M, Sogari A, Mauri G, Tosi F, Cruciani F, Sartore-Bianchi A, Siena S, Borghi F, Torri V, Élez E, Tabernero J, Nieva M, Montagut C, Tarazona N, Cervantes A, Tejpar S, Bardelli A, Marchiò C, Marsoni S, Bertotti A, Trusolino L

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Cancer Discov 2026; 270-295. doi: 10.1158/2159-8290.CD-24-0556

Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y

Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nat Med 2026; 768. doi: 10.1038/s41591-026-04242-8

Terraneo F, Ceccon M, Sapkota O, Zheng T, Brizioli M, Dello Stritto A, Cummings S, Codispoti S, Ossolengo G, Orsenigo F, Magni S, Gottinger A, Mattevi A, Fuxreiter M, Fawzi NL, Lottersberger F, Giavazzi F, d'Adda di Fagagna F

The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response.

bioRxiv 2026; . doi: 10.64898/2026.01.30.702603

Pisegna S, Scagnoli S, Gentile G, Chiavassa A, Caputo R, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Orlandi A, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri MA, Rossi L, Fiscon G, Marchetti P, Fabi A, Botticelli A

Clinical characteristics and drug-drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study.

Oncologist 2026; . doi: 10.1093/oncolo/oyaf402

Zitti B, Duval F, Wirapati P, Hicham M, Xie Y, Oh J, Hoelzl J, Meiser P, Varrone M, Peterson HM, Cianciaruso C, Bill R, Bayerl F, Bolli E, Goubet AG, Kiss M, McDowell S, Cheng P, Celestini D, Terzic J, Zwahlen T, Alouche N, Zouggari N, Tarussio D, Tissot S, Nunes-Hasler P, Mino-Kenudson M, Lanuti M, Faquin WC, Sadow PM, Tille JC, Intidhar Labidi-Galy S, Garris CS, Hugues S, Petrova TV, Ludewig B, Quezada S, Luther S, Mempel TR, Ciriello G, Pai SI, Michielin O, Böttcher JP, Weissleder R, Pittet MJ

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity.

Immunity 2026; 161-176.e12. doi: 10.1016/j.immuni.2025.11.020

Arnoult C, Attardi LD, Batsheva K, Blandino G, Burns KH, Del Sal G, Kirsch DG, Lane DP, Levine AJ, Lozano G, Malkin D, Melino G, Oren M, Prives C, Schramek D

The legacy of a gentleman scientist: Pierre Hainaut.

Cell Death Differ 2026; 1-2. doi: 10.1038/s41418-025-01586-5

Miglietta F, De Graaf M, Vernieri C, Piacentini F, Cacciatore M, Botticelli A, Vingiani A, Fotia G, Nicolè L, Griguolo G, Giarratano T, Massa D, Pellegrini V, Schiavi F, Porra F, Fassan M, Pruneri G, Dei Tos AP, Guarneri V, Kok M, Dieci MV

Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Clin Cancer Res 2025; 5306-5316. doi: 10.1158/1078-0432.CCR-25-1796

Bernard E, Cortés-Ciriano I, Gaiti F, Gan S, Jiang S, Kovatcheva M, Meisel M, Reticker-Flynn NE, Schram AM, Shoshani O, Silverbush D, Venkataramani V, Weeden CE, Zhou X

Reflections on Advances in Cancer Research in 2025.

Cancer Discov 2025; 2422-2430. doi: 10.1158/2159-8290.CD-25-1833

Eli S, Rauso G, Ghezzi P, Szczerkowski JLA, Bruzzi M, Rizzelli F, Iommazzo F, Loffreda A, Castagna F, Donà F, Gaddoni C, Dondi A, Marenda M, Rodighiero S, Tournier P, Lavagnino Z, Parazzoli D, Gauthier NC, Tamburri S, Pasini D, Habib SJ, Mapelli M

Localized Wnt-signaling promotes asymmetric NuMA-dependent oriented divisions and unequal apportioning of mitochondria.

Nat Commun 2025; 10690. doi: 10.1038/s41467-025-65775-z

Blondeaux E, Delucchi V, Mariamidze E, Bernstein-Molho R, Frank S, Ferrari A, Linn S, Kim HJ, Agostinetto E, Paluch-Shimon S, Cortesi L, Di Meglio A, Balmana J, Yerushalmi R, Rodriguez-Wallberg KA, Renaud T, Cui W, Moore HCF, Wong SM, Pogoda K, Lustberg M, Phillips KA, Han S, Puglisi F, Vernieri C, Bajpai J, Sonnenblick A, Rousset-Jablonski C, De Marchis L, De Giorgi U, Bianchini G, Texeira L, Duhoux FP, Villarreal-Garza C, Sini V, Fruscio R, Del Mastro L, Demeestere I, Azim HA, Peccatori FA, Partridge AH, Lambertini M

Breastfeeding after breast cancer in young BRCA carriers.

J Natl Cancer Inst 2025; 2229-2239. doi: 10.1093/jnci/djaf177

Toli MA, Liu X, Massa D, Lando S, Boman C, Tsiknakis N, Tranchell C, Papakonstantinou A, Fotia G, Vernieri C, Guarneri V, Bergh J, Dieci MV, Bergman LE, Matikas A, Foukakis T

Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort study.

Lancet Reg Health Eur 2025; 101432. doi: 10.1016/j.lanepe.2025.101432

Carter RD, Purnama U, Castro-Guarda M, Montes-Aparicio CN, Chandran A, Mbasu R, Ruby M, Daly C, Brisk K, Christian HC, Miller JJJJ, Buffa FM, Heather LC, Carr CA

Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.

Diabetes 2025; 1929-1945. doi: 10.2337/db25-0204

Ponzo M, Drufuca L, Buracchi C, Sindoni MM, Nucera S, Bugarin C, Bason R, Rossetti G, Bonnal R, Meli C, Rambaldi B, Lussana F, Ferrari S, Moretti A, Dastoli G, Risca G, Pellegrino C, Manz MG, Galimberti S, Rambaldi A, Gaipa G, Biondi A, Pagani M, Magnani CF

Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

J Immunother Cancer 2025; . doi: 10.1136/jitc-2025-011768

Alaimo A, Carbone FG, Buzo K, Annesi N, Genovesi S, Lorenzato A, Widmann K, Libergoli M, Marmocchi E, Bertalot G, Brolese A, Papotti MG, Molinaro L, Caffo O, Barbareschi M, Bardelli A, Romanel A, Arena S, Lunardi A

TRPM8 levels determine tumor vulnerability to channel agonists.

Mol Oncol 2025; 2905-2920. doi: 10.1002/1878-0261.70049

Talarico G, Lecchi M, Zanichelli A, Portararo P, Botti L, Cappelletti V, Costanza M, Piva A, Pratesi P, Bertolini F, Di Nicola M, Tripodo C, Cancila V, Pupa SM, Colombo MP, Chiodoni C, Verderio P, Sangaletti S

ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs.

J Exp Clin Cancer Res 2025; 264. doi: 10.1186/s13046-025-03518-0

Ward JC, Morgan M, Wood J, Woolley C, de Menezes AAN, Finch A, Sherwood K, Huang Q, Henry CS, Fernández-Tajes J, Soriano I, Thorn S, Legge I, McCullagh J, Kerr D, Kerr R, Hejmadi RK, Arends MJ, Domingo E, Maughan T, Bardella C, Tomlinson I

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.

J Pathol 2025; 40-55. doi: 10.1002/path.6446

Vitiello PP, Valsecchi AA, Duregon E, Di Celle PF, Cassoni P, Papotti M, Bardelli A, Di Maio M

KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges.

Cancers (Basel) 2025; . doi: 10.3390/cancers17172803

Matikas A, Naume B, Wildiers H, Sonke G, Dieci MV, Karakatsanis A, Andersson A, Barnekow E, Kessler LE, Einbeigi Z, Killander F, Linderholm B, Schiza A, Valachis A, Nearchou A, Engebraaten O, Porojnicu A, Soland MH, Mannsåker B, Raj SX, Blix ES, Nordstrand CS, Lambertini M, Vernieri C, Punie K, Sotiriou C, Bergh J, Villacampa G, Zouzos A, Hellström M, Hartman J, Foukakis T

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

BMJ Open 2025; e102626. doi: 10.1136/bmjopen-2025-102626

Brunet L, Alexandre D, Lee J, Blanquer-Rosselló MDM, Bracquemond D, Guernet A, Chhouri H, Goupil M, Kherrouche Z, Arabo A, Mancini M, Cartier D, Yao S, Godefroy D, Dehedin J, Li JR, Duparc C, Jamme P, Vinchent A, Bérard C, Tulasne D, Arena S, Bardelli A, Cheng C, Cho BC, Wurtz O, Coulouarn C, Maraver A, Aaronson SA, Cortot AB, Anouar Y, Grumolato L

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Nat Commun 2025; 7853. doi: 10.1038/s41467-025-61788-w

Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri A, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F

Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.

Breast 2025; 104502. doi: 10.1016/j.breast.2025.104502

D'Oria C, Cincinelli G, Bason R, Pisati F, Simoncello F, Scotti I, Giudice L, Suardi I, Ferrua P, Fossati C, Randelli PS, Caporali R, Pagani M, Ingegnoli F

Patient-Derived Explants of Osteoarthritic Synovium as Ex Vivo Model for Preclinical Research.

Int J Mol Sci 2025; . doi: 10.3390/ijms26146665

Marasco M, Kumar D, Garcia Borrego S, Seale T, Maddalena G, Mezzadra R, Belanger K, Cole S, Perez B, Luan W, Mukherjee R, Aricescu I, Markov V, Zhu Y, Arena S, Bardelli A, de Stanchina E, Lowe SW, Burkhart RA, Zimmerman JW, Yaeger R, Kopetz SE, Rosen N, Misale S

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Cancer Discov 2025; 1392-1409. doi: 10.1158/2159-8290.CD-24-0614

Gu J, Iyer A, Wesley B, Taglialatela A, Leuzzi G, Hangai S, Decker A, Gu R, Klickstein N, Shuai Y, Jankovic K, Parker-Burns L, Jin Y, Zhang JY, Hong J, Niu X, Costa JA, Pezet MG, Chou J, Chen C', Paiva M, Snoeck HW, Landau DA, Azizi E, Chan EM, Ciccia A, Gaublomme JT

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap.

Nat Biotechnol 2025; 1101-1115. doi: 10.1038/s41587-024-02386-x

Orita K, Fujibayashi S, Okuzu Y, Yamaguchi S, Goto K, Otsuki B, Kawai T, Shimizu T, Hayashi M, Ikeda N, Takaoka Y, Honda S, Ikezaki T, Matsuda S

Biocompatibility and antibacterial activity of strontium and silver ion-releasing titanium with high silver treatment concentration.

J Biomater Appl 2025; 20-35. doi: 10.1177/08853282251329276

Magaton IM, Blondeaux E, Hamy AS, Linn S, Bernstein-Molho R, Peccatori FA, Ferrari A, Carrasco E, Paluch-Shimon S, Agostinetto E, Venturelli M, Luis IMV, Rodriguez-Wallberg KA, Kim HJ, Sorouri K, Renaud T, Moore HCF, Cui W, Bajpa J, Rousset-Jablonski C, De Marchis L, Yerushalmi R, Wong SM, Han S, Phillips KA, Pogoda K, Puglisi F, Chirco A, Duhoux FP, Meattini I, Villarreal-Garza C, Vernieri C, Bruzzone M, Demeestere I, Azim HA, Partridge AH, Lambertini M

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Eur J Cancer 2025; 115434. doi: 10.1016/j.ejca.2025.115434

Blondeaux E, Sonnenblick A, Agostinetto E, Bas R, Kim HJ, Franzoi MA, Bernstein-Molho R, Linn S, Kwong A, Pogoda K, Balmana J, Smeets A, Bajpai J, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Peccatori FA, Renaud T, Ferrari A, Paluch-Shimon S, Mando P, Lee JE, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Guven DC, Lee M, Villarreal-Garza C, Hwang SE, De Marchis L, Puglisi F, Kemp Z, Meireles PA, Parokonnaya A, Werutsky G, Okano M, Azim HA, Mati K, Rosenberg S, Gelber R, Boni L, Lambertini M

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

Lancet Oncol 2025; 759-770. doi: 10.1016/S1470-2045(25)00152-4

Grassi E, Vurchio V, Cresswell GD, Catalano I, Lupo B, Sassi F, Galimi F, Borgato S, Ferri M, Viviani M, Pompei S, Urgese G, Chen B, Zanella ER, Cottino F, Russo M, Mauri G, Pietrantonio F, Zampino MG, Lazzari L, Marsoni S, Bardelli A, Lagomarsino MC, Sottoriva A, Trusolino L, Bertotti A

Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.

Sci Transl Med 2025; eado1641. doi: 10.1126/scitranslmed.ado1641

De Micheli V, Agnelli L, Conca E, Rabsiun Aramburu VL, Baggi A, Vingiani A, Duca M, Perrone F, Tamborini E, Piccolo A, Lorenzini D, Busico A, Capone I, Niger M, Proto C, Vernieri C, Manoukian S, Gancitano G, Ferrario M, Franzini JM, De Braud F, Pruneri G, Jommi C

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

BMJ Open 2025; e099134. doi: 10.1136/bmjopen-2025-099134

De Placido P, Di Rienzo R, Pietroluongo E, Martinelli C, Tafuro M, Formisano P, D'Esposito V, Poggio FB, Ruelle T, Cardinali B, Di Lauro V, Buono G, Caputo R, Buonaiuto R, Caltavituro A, Rocco P, Porciello G, De Laurentiis M, Del Mastro L, Vernieri C, Veneziani BM, Bianco R, Crispo A, De Angelis C, Arpino G, Giuliano M

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Eur J Cancer 2025; 115409. doi: 10.1016/j.ejca.2025.115409

Lambertini M, Blondeaux E, Tomasello LM, Agostinetto E, Hamy AS, Kim HJ, Franzoi MA, Bernstein-Molho R, Hilbers F, Pogoda K, Wildiers H, Bajpai J, Ignatiadis M, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Criscitiello C, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Rodriguez-Wallberg KA, Duhoux FP, Livraghi L, Bruzzone M, Boni L, Balmaña J

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.

J Clin Oncol 2025; 1706-1719. doi: 10.1200/JCO-24-01334

Alcon C, Kovatcheva M, Morales-Sánchez P, López-Polo V, Torres T, Puig S, Lu A, Samitier J, Enrich C, Serrano M, Montero J

HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.

Cell Death Differ 2025; 646-656. doi: 10.1038/s41418-024-01417-z

Stier AB, Bonaiuti P, Juhász J, Gross F, Ciliberto A

lncreased risk of slippage upon disengagement of the mitotic checkpoint.

PLoS Comput Biol 2025; e1012879. doi: 10.1371/journal.pcbi.1012879

Walsh ZH, Shah P, Kothapalli N, Shah SB, Nikolenyi G, Brodtman DZ, Leuzzi G, Rogava M, Mu M, Ho P, Abuzaid S, Vasan N, AlQuraishi M, Milner JD, Ciccia A, Melms JC, Izar B

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens.

Nat Biotechnol 2025; 384-395. doi: 10.1038/s41587-024-02235-x

Bonilla-Quintana M, Ghisleni A, Gauthier NC, Rangamani P

Dynamic mechanisms for membrane skeleton transitions.

J Cell Sci 2025; . doi: 10.1242/jcs.263473

Schoenpflug LA, Chatzipli A, Sirinukunwattana K, Richman S, Blake A, Robineau J, Mertz KD, Verrill C, Leedham SJ, Hardy C, Whalley C, Redmond K, Dunne P, Walker S, Beggs AD, McDermott U, Murray GI, Samuel LM, Seymour M, Tomlinson I, Quirke P, Rittscher J, Maughan T, Domingo E, Koelzer VH

Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.

J Pathol 2025; 184-197. doi: 10.1002/path.6376

Fabi A, Rossi A, Caputo R, Pisegna S, Scagnoli S, Pantano F, D'Auria G, Fedele P, Fabbri A, Vernieri C, Palleschi M, Carbognin L, Ferretti G, Di Monte E, Paris I, Pavese F, Garrone O, Franco A, De Laurentiis M, Franceschini G, Scambia G, Giannarelli D, Masetti R, Botticelli A

Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.

NPJ Precis Oncol 2025; 22. doi: 10.1038/s41698-025-00801-3

Protasoni M, López-Polo V, Stephan-Otto Attolini C, Brandariz J, Herranz N, Mateo J, Ruiz S, Fernandez-Capetillo O, Kovatcheva M, Serrano M

Cyclophilin D plays a critical role in the survival of senescent cells.

EMBO J 2024; 5972-6000. doi: 10.1038/s44318-024-00259-2

%PLACEHOLDER%